Stockreport

Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... [Yahoo! Finance]

Bioventus Inc. - Class A  (BVS) 
PDF Adjusted Gross Margin: 75%, comparable to last year, down 10 basis points. Surgical Solutions Revenue: Increased by 18%, with both ultrasonics and bone graft substitu [Read more]